GTx
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch GTx and buy or sell other stocks, ETFs, and their options commission-free!About GTXI
Oncternal Therapeutics, Inc. engages in the development of novel oncology therapies for the treatment of cancers with critical unmet medical need. Its product pipeline include Zilovertamab, ONCT-216, ONCT-808 and ONCT-534.
CEOJames B. Breitmeyer, MD, PhD
CEOJames B. Breitmeyer, MD, PhD
Employees—
Employees—
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded1997
Founded1997
Employees—
Employees—
GTXI Key Statistics
Market cap—
Market cap—
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume—
Average volume—
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.5266
52 Week high$0.5266
52 Week low$0.5266
52 Week low$0.5266
Stock Snapshot
As of today, GTx(GTXI) shares are valued at $3.94.
On 2026-09-08, GTx(GTXI) stock opened at —, reached a high of —, and a low of —.
The GTx(GTXI)'s current trading volume is 0.
In the last year, GTx(GTXI) shares hit a 52-week high of $0.53 and a 52-week low of $0.53.
In the last year, GTx(GTXI) shares hit a 52-week high of $0.53 and a 52-week low of $0.53.